פרגניל 5000 יח' בינל
merck sharp & dohme israel ltd - human chorionic gonadotropin - אבקה להכנת תמיסה לזריקה - human chorionic gonadotropin 5000 iu/ml - chorionic gonadotrophin - chorionic gonadotrophin - in the female: ovulation induction in infertility due to anovulation or impaired follicle-ripening. preparation of follicles for puncture in controlled ovarian hyperstimulation programs. luteal phase support. in the male: hypogonadotropic hypogonadism (also cases of idiopathic dysspermias have shown a positive response to gonadotropins). delayed puberty associated with insufficient gonadotropic pituitary function.cryptorchidism not due to anatomical obstruction.
אומרי-הפ-בי % 5
omrix biopharmaceuticals ltd, israel - human immunoglobulin - תמיסה להזרקה - human immunoglobulin 5 g / 100 ml - specific immunoglobulins - passive immunization for the prevention of hepatitis b virus re-infection after liver transplantation.
אוקטאפלאס אל.ג'י
dover medical & scientific equipment ltd, israel - human plasma protein - תמיסה לאינפוזיה - human plasma protein 45 - 70 mg/ml - other plasma protein fractions
בריפלקס pn 250
csl behring ltd., israel - coagulation factor ii (human); coagulation factor ix (human- rfixfc); coagulation factor vii (human); coagulation factor x (human); protein c; protein s antigen - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ii (human) 200 - 480 iu; coagulation factor vii (human) 100 - 250 iu; coagulation factor ix (human- rfixfc) 200 - 310 iu; coagulation factor x (human) 220 - 600 iu; protein c 150 - 450 iu; protein s antigen 120 - 380 iu - coagulation factor ix, ii, vii and x in combination - coagulation factor ix, ii, vii and x in combination - -treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required.
בריפלקס pn 500
csl behring ltd., israel - coagulation factor ii (human); coagulation factor ix (human- rfixfc); coagulation factor vii (human); coagulation factor x (human); protein c; protein s antigen - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ii (human) 400 - 960 iu; coagulation factor vii (human) 200 - 500 iu; coagulation factor ix (human- rfixfc) 400 - 620 iu; coagulation factor x (human) 440 - 1200 iu; protein c 300 - 900 iu; protein s antigen 240 - 760 iu - coagulation factor ix, ii, vii and x in combination
קובאלטרי iu 1000
bayer israel ltd - recombinant human coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - recombinant human coagulation factor viii 1000 iu - coagulation factor viii
קובאלטרי iu 2000
bayer israel ltd - recombinant human coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - recombinant human coagulation factor viii 2000 iu - coagulation factor viii
קובאלטרי iu 250
bayer israel ltd - recombinant human coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - recombinant human coagulation factor viii 250 iu - coagulation factor viii
קובאלטרי iu 500
bayer israel ltd - recombinant human coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - recombinant human coagulation factor viii 500 iu - coagulation factor viii
פולמוזיים
roche pharmaceuticals (israel) ltd - recombinant human deoxyribonuclease - תמיסה לשאיפה - recombinant human deoxyribonuclease 1 mg/ml - dornase alfa (desoxyribonuclease) - dornase alfa (desoxyribonuclease) - management of cystic fibrosis not for patients under 5 years of age or with fvc<40% .